These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 21569804)

  • 1. Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor.
    Li Y; Wang J; Wientjes MG; Au JL
    Adv Drug Deliv Rev; 2012 Jan; 64(1):29-39. PubMed ID: 21569804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical and dental applications of nanomedicines.
    Kavoosi F; Modaresi F; Sanaei M; Rezaei Z
    APMIS; 2018 Oct; 126(10):795-803. PubMed ID: 30264432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicines: Redefining traditional medicine.
    Lu W; Yao J; Zhu X; Qi Y
    Biomed Pharmacother; 2021 Feb; 134():111103. PubMed ID: 33338747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern.
    Lam PL; Wong WY; Bian Z; Chui CH; Gambari R
    Nanomedicine (Lond); 2017 Feb; 12(4):357-385. PubMed ID: 28078952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomedicine: a new frontier in cancer therapeutics.
    Lee PY; Wong KK
    Curr Drug Deliv; 2011 May; 8(3):245-53. PubMed ID: 21291378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Influencing the Delivery Efficiency of Cancer Nanomedicines.
    Ullah R; Wazir J; Khan FU; Diallo MT; Ihsan AU; Mikrani R; Aquib M; Zhou X
    AAPS PharmSciTech; 2020 May; 21(4):132. PubMed ID: 32409932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Applications of Nanotechnology in Drug Delivery and Medical Imaging: Review.
    Singh S; Sharma H
    Curr Radiopharm; 2023; 16(4):269-283. PubMed ID: 37345242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of reflecting on treatment and post-treatment care when assessing the social aspects of cosmetic nanomedicine and transdermal delivery system.
    Duché G; Thordarson P; Kearnes M
    Nanomedicine; 2020 Aug; 28():102214. PubMed ID: 32360550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized Cancer Nanomedicine: Overcoming Biological Barriers for Intracellular Delivery of Biopharmaceuticals.
    López-Estévez AM; Lapuhs P; Pineiro-Alonso L; Alonso MJ
    Adv Mater; 2024 Apr; 36(14):e2309355. PubMed ID: 38104275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology for the diagnosis and treatment of diseases.
    Azzawi M; Seifalian A; Ahmed W
    Nanomedicine (Lond); 2016 Aug; 11(16):2025-7. PubMed ID: 27509317
    [No Abstract]   [Full Text] [Related]  

  • 12. Artificial intelligence aids in development of nanomedicines for cancer management.
    Tan P; Chen X; Zhang H; Wei Q; Luo K
    Semin Cancer Biol; 2023 Feb; 89():61-75. PubMed ID: 36682438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedical engineering: shaping future nanomedicines.
    Luo D; Carter KA; Lovell JF
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(2):169-88. PubMed ID: 25377691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrohydrodynamic Preparation of Nanomedicines.
    Rasekh M; Smith A; Arshad MS; Gunduz O; Van der Merwe SM; Smith G; Ahmad Z
    Curr Top Med Chem; 2015; 15(22):2316-27. PubMed ID: 26043737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in Targeted Tumor Chemotherapy Based on Smart Nanomedicines.
    Qin SY; Zhang AQ; Zhang XZ
    Small; 2018 Nov; 14(45):e1802417. PubMed ID: 30247806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Not just for tumor targeting: unmet medical needs and opportunities for nanomedicine.
    Lepeltier EA; Nuhn L; Lehr CM; Zentel R
    Nanomedicine (Lond); 2015; 10(20):3147-66. PubMed ID: 26447353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor extravasation and infiltration as barriers of nanomedicine for high efficacy: The current status and transcytosis strategy.
    Zhou Q; Dong C; Fan W; Jiang H; Xiang J; Qiu N; Piao Y; Xie T; Luo Y; Li Z; Liu F; Shen Y
    Biomaterials; 2020 May; 240():119902. PubMed ID: 32105817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second world conference on nanomedicine and drug delivery.
    Ninan N; Thomas S; George A; Sebastian M
    Ther Deliv; 2011 Jun; 2(6):711-5. PubMed ID: 22822503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thinking small, doing big: Current success and future trends in drug delivery systems for improving cancer therapy with special focus on liver cancer.
    Limeres MJ; Moretton MA; Bernabeu E; Chiappetta DA; Cuestas ML
    Mater Sci Eng C Mater Biol Appl; 2019 Feb; 95():328-341. PubMed ID: 30573256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spatiotemporal journey of nanomedicines in solid tumors on their therapeutic efficacy.
    Qin M; Xia H; Xu W; Chen B; Wang Y
    Adv Drug Deliv Rev; 2023 Dec; 203():115137. PubMed ID: 37949414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.